企业管治

Search documents
广南(集团)(01203.HK)委任德勤为公司新核数师
Ge Long Hui· 2025-09-25 09:48
董事会进一步宣布,根据审核委员会的建议,董事会决议委任德勤为公司新核数师,以填补毕马威会计 师事务所辞任后的临时空缺。德勤的任期直至公司下届股东周年大会结束为止。 格隆汇9月25日丨广南(集团)(01203.HK)公布,经考虑毕马威会计师事务所已担任公司的核数师超过20 年,董事会已检讨更换核数师的需要。董事会及公司审核委员会认为,为维护良好的企业管治、保持公 司外聘核数师的独立性及客观性,并符合公司及公司股东的整体利益,现为轮换公司核数师的适当时 机。因此,董事会宣布毕马威会计师事务所已辞任公司核数师,自2025年9月25日起生效。 ...
强制退市与私有化并行 年内40家港股公司“离场”
Shang Hai Zheng Quan Bao· 2025-09-05 20:34
Group 1 - The pace of delisting in the Hong Kong stock market has accelerated, with 40 companies delisted by September 5, 2025, compared to 32 in the same period last year [1][2] - In the A-share market, 23 companies have been delisted by the end of August 2025, with 9 occurring since July [1][2] - The delisting trends in both markets reflect a comprehensive optimization of the corporate ecosystem, driven by regulatory changes aimed at enhancing market governance [1][2][11] Group 2 - The "fast-track delisting mechanism" in Hong Kong has led to a significant number of "zombie stocks" being removed from the market, particularly in the real estate and non-bank financial sectors [2][3] - Companies like China Evergrande and others in the real estate sector were delisted due to prolonged suspension of trading, highlighting the impact of the new delisting regulations [2][3] - The concentration of delisted companies is attributed to the ongoing macroeconomic pressures and the effectiveness of the 2018 delisting regulations [3][4] Group 3 - There has been a notable increase in privatization cases in the Hong Kong market, with 19 companies privatized in 2025, marking a significant rise compared to previous years [6][8] - The privatization of Beijing Construction, which was acquired at a 250% premium over its last trading price, exemplifies the trend of companies seeking greater strategic flexibility post-privatization [7][8] - The motivations for privatization include addressing valuation gaps and enhancing strategic freedom for long-term business restructuring [8][9] Group 4 - The trend of privatization is also driven by the need for companies to escape the constraints of public market expectations, allowing for more effective long-term strategic planning [9][10] - The acquisition of Yuefeng Environmental by a subsidiary of Hanlan Environment for approximately 11.099 billion HKD illustrates the ongoing consolidation in the environmental sector [10] - The overall delisting and privatization trends indicate a shift towards a more elite and efficient market structure in Hong Kong [10][11]
复星国际(00656) - 自愿公告-关於菜鸟智慧物流网络有限公司之争议解决
2025-08-29 09:58
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準 確性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 自願公告 關於菜鳥智慧物流網絡有限公司之 爭議解決 本公告乃復星國際有限公司(「 本公司 」,連同其附屬公司統稱「本集團 」) 自願刊發。 本公司股東及潛在投資者於買賣本公司之證券時務請審慎行事。 茲提述本公司 分別於 2025 年 3 月 28 日及 2025 年 3 月 30 日刊發之盈利警告 公告(「盈利警告公告 」)及截至 2024 年 12 月 31 日止年度 之 業績公告, 以 及 於 2025 年 4 月 25 日刊發之 本公司 年報。除文義另有所指外,本公告所使用 之詞彙與盈利警告公告所界定者具有相同涵義。 本公司 董事 會 (「董事會 」)謹 此 通知 本 公司 之 股東 及 潛在 投資 者 ,於 2025 年 8 月 29 日 ,Stater Investment Holdings Limited(「SIHL」)( 本公 司 之全 資 附屬 公 司 ) 與 菜 鳥 智 慧 物 流 網 ...
中国海油: 审核委员会章程
Zheng Quan Zhi Xing· 2025-08-27 10:29
Group 1 - The Audit Committee is responsible for overseeing the integrity of the company's financial statements, the independence and performance of external auditors, compliance with legal regulations, and monitoring the company's risk management and internal control systems [1][10][18] - The majority of the Audit Committee members should be independent non-executive directors with relevant experience, including at least one member with accounting or financial management expertise [2][7] - The Audit Committee must meet at least once a year in person, with additional meetings conducted via teleconference or electronic communication, ensuring that all meeting documents are distributed at least three days in advance [2][4] Group 2 - The Audit Committee has the authority to review and monitor the independence of external auditors and to address any issues related to their appointment, resignation, or dismissal [7][9] - The committee is tasked with evaluating the effectiveness of the company's internal audit function and ensuring it has adequate resources and authority [12][14] - The committee must also review the company's risk management and internal control systems annually, including any significant findings related to financial reporting and compliance with applicable regulations [10][11][15] Group 3 - The Audit Committee is required to communicate regularly with external auditors and management regarding any significant issues arising during the audit process [6][8] - The committee should establish a whistleblower policy to allow employees and other stakeholders to report concerns about financial reporting or internal controls confidentially [10][15] - The committee is responsible for recommending the appointment or dismissal of the Chief Financial Officer to the board [10][11]
荣昌生物: 荣昌生物第二届董事会第二十八次会议决议公告
Zheng Quan Zhi Xing· 2025-08-22 10:21
Group 1 - The board of directors of Rongchang Biopharmaceuticals held its 28th meeting, with all 9 directors present, confirming compliance with relevant laws and regulations [1][2] - The board approved the unaudited consolidated financial statements for the six months ending June 30, 2025, which were reviewed by the audit committee [1][3] - The board decided not to declare an interim dividend for 2025, considering the company's overall financial condition and capital needs [2][3] Group 2 - The board approved the company's 2025 interim report and its summary, ensuring compliance with regulations and confirming the accuracy and completeness of the information [2][3] - A special report on the use of raised funds for the first half of 2025 was also approved, with details available on the Shanghai Stock Exchange website [3][5] - The board reviewed and confirmed the effectiveness of the company's risk management and internal control systems for the first half of 2025 [4][5] Group 3 - The board confirmed compliance with the Corporate Governance Code and related rules, with no violations reported during the first half of 2025 [4][5] - An evaluation report on the "Quality Improvement and Efficiency Enhancement" action plan for 2025 was approved, summarizing the execution status for the first half of the year [4][5] - The board approved changes to the registered capital and amendments to the company's articles of association following the issuance of 19 million H shares on May 29, 2025 [5][6] Group 4 - The board reviewed the progress of the company's Environmental, Social, and Governance (ESG) goals for 2025, focusing on sustainable development and social responsibility [5][6]
陆控(6623/LU)任命新独立非执行董事,以进一步加强董事会独立性
Quan Jing Wang· 2025-08-14 12:58
Core Viewpoint - The appointment of Ms. Li Huiping as an independent non-executive director aims to enhance board diversity, strengthen board independence, and increase the representation of women on the board [1] Group 1: Appointment Details - Ms. Li Huiping has over 40 years of experience in multinational finance and legal sectors, having worked with major international financial institutions such as Mizuho Bank, Standard Chartered Bank, and BNP Paribas [1] - She obtained her Hong Kong lawyer qualification in 1995 and progressed from a lawyer to a partner at Paul Hastings LLP [1] - Since 2001, she has held key legal positions at HSBC in the Asia-Pacific region, focusing on retail, private, and commercial banking [1] Group 2: Governance and Compliance - The appointment is in response to the revised corporate governance code that will take effect on July 1, 2025, under the listing rules [1] - The initiative is part of a broader strategy to improve corporate governance practices within the company [1]
清晰医疗:撤销谢伟业的董事职位
Zhi Tong Cai Jing· 2025-08-01 14:43
Group 1 - The company announced the removal of Dr. Xie Weiyi from the board due to unresolved legal disputes and bankruptcy petitions against him, as well as formal notifications from the Hong Kong government regarding his unpaid debts [1] - The board sought legal advice from Cayman Islands counsel regarding the interpretation of Article 86(4) of the company's articles of association, which pertains to the disqualification of directors who suspend debt repayment or reach settlement agreements with creditors [1] - A board meeting was held on August 1, 2025, where a majority decision was made to revoke Dr. Xie Weiyi's directorship, effective immediately, with two directors opposing the decision due to conflicts of interest [1] Group 2 - Mr. Wang Can, an independent non-executive director, appointed Mr. Jiang Bo, an executive director, as his alternate to vote on resolutions during the board meeting, without extending this appointment to other roles [2]
香港《企业管治守则》及《上市规则》修订深度解析:企业应对之道与治理升级路径
Sou Hu Cai Jing· 2025-07-31 02:52
Core Viewpoint - The Hong Kong Stock Exchange (HKEX) has officially released a consultation summary regarding the review of the Corporate Governance Code and Listing Rules, marking the most significant change in governance standards in nearly a decade, with the revisions set to take effect on July 1, 2025 [2] Group 1: Historical Context and Trends - The Corporate Governance Code has undergone eight revisions since its introduction in 2004, reflecting HKEX's commitment to enhancing corporate governance and aligning with international best practices [5] - Key revisions occurred in 2004 (introduction of the framework), 2012-2013 (enhanced board independence and diversity), 2016 (strengthened risk internal control), 2018 (improved transparency and diversity), 2021 (comprehensive upgrades), and 2024 (efficiency optimization) [5] Group 2: Key Revisions and Requirements - Mandatory establishment of three key committees (Audit, Nomination, and Remuneration Committees) with higher requirements for the number, qualifications, roles, and independence of independent non-executive directors [6] - Enhanced transparency and disclosure requirements transitioning from voluntary "best practice" to mandatory "Corporate Governance Reports," necessitating detailed disclosures on compliance, deviations, and governance practices [7] - Risk management is now a core supervisory responsibility of the board, with mandatory annual effectiveness assessments and disclosures [8] - Diversity policies are now mandatory, particularly regarding gender diversity, with requirements to disclose targets and progress [9] - Continuous optimization of board composition, including term limits for independent directors and mandatory training and performance evaluations to ensure board vitality and independence [10] Group 3: Governance Effectiveness and Training - The revisions emphasize the need for a governance effectiveness-focused training system for directors, including mandatory annual training on specific topics [14] - Boards are required to conduct comprehensive performance evaluations at least every two years, with disclosures on evaluation scope, methods, results, and improvement measures [14] - Enhanced shareholder communication management is mandated, requiring detailed disclosures on the nature, frequency, and follow-up mechanisms of shareholder interactions [18] Group 4: Independence and Diversity - New hard constraints on board independence include a nine-year term limit for independent non-executive directors, with a three-year cooling-off period for reappointment [19] - Independent directors are limited to serving on a maximum of six boards, with additional disclosure requirements [20] - The diversity policy now extends beyond the board to all employees, requiring companies to develop and disclose diversity policies for all staff [22] Group 5: Risk Management and Internal Control - The revisions harden previous soft requirements for risk management, mandating effective evaluations and disclosures of risk management and internal control systems [25] - Companies must establish a comprehensive risk management framework that integrates risk identification, compliance, and internal control processes [28] - Mandatory disclosures on the effectiveness of risk management and internal control systems are now required, including specific evaluation processes and findings [27] Group 6: Capital Management and Shareholder Returns - New regulations enhance disclosure requirements regarding shareholder returns, including mandatory disclosures of dividend policies and the rationale for any non-distributions [35] - Companies are required to construct a dynamic dividend policy framework and regularly review and optimize their dividend policies in alignment with corporate strategy and financial status [35]
百济神州: 提名及企业管治委员会章程
Zheng Quan Zhi Xing· 2025-05-28 10:53
Core Points - The Nomination and Corporate Governance Committee of the company is established to identify qualified individuals for board membership and to provide recommendations for nominees at the annual shareholder meetings [6] - The committee is composed entirely of independent directors as per NASDAQ rules, with a minimum of two members [1] - The committee is responsible for reviewing and recommending changes to corporate governance guidelines and conducting annual performance evaluations of the board and its committees [3][6] Group 1: Committee Structure and Meetings - The committee members are appointed annually by the board and can be replaced at any time by the board [1] - Meetings can be held in person or via telecommunication, with a quorum established by a majority of members [2] - The committee chair collaborates with members to set meeting agendas, which should be provided in advance [2] Group 2: Responsibilities and Powers - The committee is tasked with reviewing the appropriateness of its charter annually and advising the board on significant developments in corporate governance [3] - It is responsible for establishing a process for identifying and recommending nominees for the board, including shareholder nominations [4] - The committee evaluates the independence of non-executive directors and oversees the hiring and termination of search firms for board candidates [9] Group 3: Succession Planning and Education - The committee provides recommendations for succession planning for key management positions, including the CEO [5] - It is also responsible for preparing educational materials and courses for directors to assist them in fulfilling their duties [9]
李宁宣布不续聘普华永道
Zhong Guo Ji Jin Bao· 2025-05-14 14:53
Group 1 - The core point of the article is that Li Ning has announced the appointment of Ernst & Young as its new auditor, replacing PwC, which will not be renewing its contract after the upcoming annual general meeting on June 12 [1][3][5] - Li Ning's audit committee and board of directors recommended the change to ensure good corporate governance and maintain the independence and objectivity of external auditors [5] - The decision to appoint Ernst & Young was based on several factors, including their experience with Hong Kong-listed companies, industry knowledge, familiarity with listing rules and international accounting standards, and audit fees [5] Group 2 - Li Ning has been audited by PwC since its listing in 2004, and the change marks a significant shift in its auditing practices [5] - The audit fees paid to PwC for 2023 and 2024 were reported as 9.355 million yuan and 8.828 million yuan respectively, indicating a slight decrease in fees [6] - The ongoing trust crisis surrounding PwC, particularly due to the Evergrande audit case, has led to multiple companies terminating their contracts with them since April 2024 [8][10]